Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity.
de Bono JS, Rha SY, Stephenson J, Schultes BC, Monroe P, Eckhardt GS, Hammond LA, Whiteside TL, Nicodemus CF, Cermak JM, Rowinsky EK, Tolcher AW. de Bono JS, et al. Among authors: monroe p. Ann Oncol. 2004 Dec;15(12):1825-33. doi: 10.1093/annonc/mdh472. Ann Oncol. 2004. PMID: 15550589 Free article. Clinical Trial.
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer.
Takimoto CH, Hammond-Thelin LA, Latz JE, Forero L, Beeram M, Forouzesh B, de Bono J, Tolcher AW, Patnaik A, Monroe P, Wood L, Schneck KB, Clark R, Rowinsky EK. Takimoto CH, et al. Among authors: monroe p. Clin Cancer Res. 2007 May 1;13(9):2675-83. doi: 10.1158/1078-0432.CCR-06-2393. Clin Cancer Res. 2007. PMID: 17473199 Clinical Trial.
Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies.
Ochoa L, Hurwitz HI, Wilding G, Cohen D, Thomas JP, Schwartz G, Monroe P, Petros WP, Ertel VP, Hsieh A, Hoffman C, Drengler R, Magnum S, Rowinsky EK. Ochoa L, et al. Among authors: monroe p. Ann Oncol. 2000 Oct;11(10):1313-22. doi: 10.1023/a:1008379802642. Ann Oncol. 2000. PMID: 11106122 Free article. Clinical Trial.
Brain changes underlying progression of speech motor programming impairment.
Landin-Romero R, Liang CT, Monroe PA, Higashiyama Y, Leyton CE, Hodges JR, Piguet O, Ballard KJ. Landin-Romero R, et al. Among authors: monroe pa. Brain Commun. 2021 Sep 2;3(3):fcab205. doi: 10.1093/braincomms/fcab205. eCollection 2021. Brain Commun. 2021. PMID: 34541532 Free PMC article.
75 results